MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Repro Med Systems Operating Cash Flow 2011-2026 | KRMD
Annual Operating Cash Flow Repro Med Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 462 K | -320 K | -4.89 M | -5.4 M | -4.32 M | -743 K | 321 K | 1.48 M | 900 K | - | 826 K | 954 K | 785 K | 561 K | 1.03 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.48 M | -5.4 M | -597 K |
Quarterly Operating Cash Flow Repro Med Systems
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.7 K | - | - | -237 K | - | - | - | -347 K | - | - | - | -4.66 M | - | -6.74 M | - | -1.75 M | - | -3.6 M | - | -2.61 M | - | 968 K | 2.71 M | 153 K | - | -502 K | -1.48 M | -1.05 M | - | 1.35 M | 956 K | -13.1 K | - | 497 K | -271 K | 143 K | - | -213 K | - | - | - | - | 11.1 K | - | - | - | 220 K | - | - | 599 K | 498 K | - | - | 504 K | 377 K | - | - | 258 K | 172 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.71 M | -6.74 M | -484 K |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
796 M | $ 68.16 | -0.67 % | $ 13.6 B | USA |
 |
Glaukos Corporation
GKOS
|
-14.8 M | $ 122.57 | -2.98 % | $ 7.01 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 66.92 | -1.44 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 418.06 | -2.01 % | $ 149 B | USA |
 |
ICU Medical
ICUI
|
180 M | $ 142.66 | 0.46 % | $ 3.52 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 114.32 | 0.43 % | $ 3.66 B | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 95.36 | -1.28 % | $ 2.16 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 1.8 | -1.37 % | $ 82.4 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.4 | 2.67 % | $ 32.8 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 67.27 | -0.36 % | $ 3.98 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 9.64 | 1.25 % | $ 81.8 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 24.65 | 0.24 % | $ 4.14 B | USA |
 |
Haemonetics Corporation
HAE
|
293 M | $ 79.6 | 1.13 % | $ 3.76 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.34 B | $ 210.28 | -1.16 % | $ 20.6 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 29.84 | -0.1 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 8.93 | -0.89 % | $ 184 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 330.59 | -1.22 % | $ 23.9 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 68.56 | 0.72 % | $ 222 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 24.9 | -3.38 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.39 | -0.81 % | $ 2.07 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.68 | -1.18 % | $ 20.4 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 63.12 | -2.89 % | $ 208 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | $ 27.32 | -0.83 % | $ 1.3 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.85 | -0.27 % | $ 168 M | USA |
 |
Baxter International
BAX
|
845 M | $ 20.55 | 2.6 % | $ 10.5 B | USA |
 |
ResMed
RMD
|
351 M | $ 196.09 | -0.43 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 27.3 | - | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.18 | 2.32 % | $ 274 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 12.37 | 0.2 % | $ 505 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 150.38 | -1.09 % | $ 43.3 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.24 | -0.46 % | $ 34.4 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 4.17 | -1.77 % | $ 306 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 131.82 | 1.3 % | $ 7.41 M | USA |